All Web Images Videos News
Settings
Appearance
Site Icons
Font Size
Font
General
Infinite Scroll
Open Links in a New Tab
Safe Search

Abbvie products

Related questions
What are Abbvie products? View names, product characteristics and patient information for our products. In Australia, AbbVie has a diverse product portfolio that supports a range of disease areas including immunology and neuroscience. Our portfolio of biologics and specialty-focused medicines currently benefit more than 31,000 Australians.
How many employees does AbbVie have? AbbVie employs about 30,000 people in 75 countries. Its headquarters is in Lake Bluff, Illinois, which is a part of the Chicago metropolitan area. Richard A. Gonzalez is AbbVie’s CEO. The company’s products brought in total revenues of $28.2 billion in 2017. The drugmaker focuses on immunology, oncology, neuroscience and virology.
Does AbbVie provide medicine at no cost? U.S patients provided medicine at no cost through our patient assistance programs. We work with multiple global partners to provide AbbVie products needed to support low-income countries, medical missions, war zones and natural disasters. Our partners include organizations such as Direct Relief, Americares, Operation Smile and many more.
How does AbbVie help patients get the medicines they need? At AbbVie, we believe everyone should have access to quality and affordable medicines if and when they need them. We help patients get the medicines they need by offering various access and support programs. Our solutions start with the patient perspective.
Trends
Related Searches
Products | AbbVie
Learn about the products AbbVie offers for various conditions, such as arthritis, cancer, diabetes, and more. Find names and safety data sheets, medical information requests, and patient assistance …
https://www.abbvie.com/patients/products.html
Pharmaceutical Research & Development | AbbVie
AbbVie is a global biopharmaceutical company that develops and delivers innovative medicines for patients with various conditions. Learn about AbbVie's science, …
https://www.abbvie.com/
AbbVie - Wikipedia
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary...
https://en.wikipedia.org/wiki/AbbVie
Allergan is now part of AbbVie | AbbVie
Our products. We offer over 30+ brands treating 60+ conditions from oncology and immunology to aesthetics and eye care. Search our global list of products or filter by therapeutic area. learn more. Aesthetics. With a …
https://www.abbvie.com/allergan.html
Immunology | AbbVie
AbbVie is a trusted leader in immunology research and development, exploring new disease areas, creating personalized solutions and offering medicines for some of the most challenging immunological …
https://www.abbvie.com/science/areas-of-focus/immunology.html
Patients | AbbVie
Delivering more than medicine. At AbbVie, we believe everyone should have access to quality and affordable medicines if and when they need them. We help patients get the medicines they need by offering various …
https://www.abbvie.com/patients.html
Pipeline | AbbVie
AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
https://www.abbvie.com/science/pipeline.html
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) …
PRODUODOPA is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations in people living …
https://news.abbvie.com/2024-01-09-AbbVie-Launches-PRODUODOPA-R-foslevodopa-foscarbidopa-for-People-...
U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive …
NORTH CHICAGO, Ill., Dec. 16, 2022 / PRNewswire / -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR …
https://news.abbvie.com/2022-12-16-U-S-FDA-Approves-VRAYLAR-R-cariprazine-as-an-Adjunctive-Treatment...
Oncology Research & Treatment | AbbVie
Jennifer. CLL patient. Building on expertise to tackle the toughest cancers. Our scientific research has led to critical discoveries in the treatment of blood cancer. …
https://www.abbvie.com/science/areas-of-focus/oncology.html
See more